BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4857058)

  • 21. Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.
    Fears R; Hibbs MJ; Smith RA
    Biochem J; 1985 Jul; 229(2):555-8. PubMed ID: 4041182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The formation of a fibrinogen-activator complex by the action of streptokinase.
    Chesterman CN; Cederholm-Williams SA; Allington MJ; Sharp AA
    Thromb Res; 1977 Mar; 10(3):421-30. PubMed ID: 854878
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative activation kinetics of mammalian plasminogens.
    Wohl RC; Sinio L; Summaria L; Robbins KC
    Biochim Biophys Acta; 1983 May; 745(1):20-31. PubMed ID: 6682680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal plasminogen Maywood I.
    Robbins KC; Boreisha IG; Godwin JE
    Thromb Haemost; 1991 Nov; 66(5):575-80. PubMed ID: 1803622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esterase activities in the zymogen moiety of the streptokinase-plasminogen complex.
    Reddy KN; Markus G
    J Biol Chem; 1974 Aug; 249(15):4851-7. PubMed ID: 4858737
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of commercially available plasminogen preparations in vitro: purity and reactivity.
    Miyashita C; Heiden M; Leipnitz G; Pindur G; Wenzel E
    Haemostasis; 1988; 18 Suppl 1():121-6. PubMed ID: 3350393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of carcinogenic aminoazo dye-binding protein and its identification as alcohol dehydrogenase.
    Tokuma Y; Terayama H
    Biochem Biophys Res Commun; 1973 Sep; 54(1):341-9. PubMed ID: 4200396
    [No Abstract]   [Full Text] [Related]  

  • 28. Further evidence for an active center in streptokinase-plasminogen complex; interaction with pancreatic trypsin inhibitor.
    Reddy KN; Markus G
    Biochem Biophys Res Commun; 1973 Apr; 51(3):672-9. PubMed ID: 4267404
    [No Abstract]   [Full Text] [Related]  

  • 29. Site-specific alteration of Gly-24 in streptokinase: its effect on plasminogen activation.
    Lee BR; Park SK; Kim JH; Byun SM
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1085-90. PubMed ID: 2575377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 31. Activator activities of the transient forms of the human plasminogen-streptokinase complex during its proteolytic conversion to the stable activator complex.
    Markus G; Evers JL; Hobika GH
    J Biol Chem; 1976 Nov; 251(21):6495-504. PubMed ID: 135763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on streptokinase. Purification and some molecular properties.
    BiliƄski T; Loch T; Zakrzewski K
    Acta Biochim Pol; 1968; 15(1):123-8. PubMed ID: 5656023
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinetics of active center formation in dog plasminogin by streptokinase and activity of a modified streptokinase.
    Reddy KN
    J Biol Chem; 1976 Nov; 251(21):6624-9. PubMed ID: 977590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of abnormal plasminogens: dysplasminogenemias.
    Robbins KC
    Semin Thromb Hemost; 1990 Jul; 16(3):217-20. PubMed ID: 2146745
    [No Abstract]   [Full Text] [Related]  

  • 35. Conformation ability test of human, rabbit and bovine plasminogens and their specific interaction with streptokinase.
    Nikandrov VN; Vorobyova GV; Yankovskaya GS; Demidchik NV
    Int J Biol Macromol; 1992 Aug; 14(4):229-34. PubMed ID: 1504045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The activation and inhibition of fibrinolysis.
    Castellino FJ; Schick LA; Brockway WJ; Sodetz JM
    Adv Exp Med Biol; 1975; 63():233-43. PubMed ID: 128278
    [No Abstract]   [Full Text] [Related]  

  • 37. Streptokinase-dependent potentiating factor (SK-potentiator) for plasminogen activation from human plasma: its identification as a fibrinogen degradation product.
    Hishikawa-Itoh Y; Sugie I; Kato H; Iwanaga S
    J Biochem; 1982 Oct; 92(4):1129-40. PubMed ID: 6890955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrin binding. An essential property of anisoylated plasminogen streptokinase activator complex.
    Banton CJ; Overell BG
    Drugs; 1987; 33 Suppl 3():93-6. PubMed ID: 2824169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct evidence for the generation of an active site in the plasminogen moiety of the streptokinase-human plasminogen activator complex.
    Schick LA; Castellino FJ
    Biochem Biophys Res Commun; 1974 Mar; 57(1):47-54. PubMed ID: 4828190
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.
    Unkeless J; Dano K; Kellerman GM; Reich E
    J Biol Chem; 1974 Jul; 249(13):4295-305. PubMed ID: 4368727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.